Trial site
Nemocnice Jihlava prispevkova organizace
- 21running trials
- 14closed trials
The trials here
What the 35 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis18 trials
- Obesity4 trials
- Stroke3 trials
- Type 1 diabetes3 trials
- Migraine2 trials
- Asthma1 trial
- Atrial fibrillation1 trial
- COPD1 trial
- Heart failure1 trial
- Hidradenitis suppurativa1 trial
- Parkinson disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 327 trials
- Phase 24 trials
- Phase 12 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting14 trials
- Completed14 trials
- Not yet recruiting4 trials
- Recruiting3 trials
- Lead sponsor
- Sanofi5 trials
- Hoffmann-La Roche3 trials
- Amgen Inc.2 trials
- Eli Lilly and Company2 trials
- Ipsen2 trials
- and 18 more
Running trials
Not yet recruiting
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis5 recruiting
- Atrial fibrillation1 recruiting
- Parkinson disease1 recruiting
- Stroke1 recruiting
Closed trials
Active, not recruiting
Completed
Active, not recruiting
Active, not recruiting
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026